A detailed history of Black Rock Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 122,531,027 shares of GILD stock, worth $7.88 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares
122,531,027
Previous 122,793,011 0.21%
Holding current value
$7.88 Billion
Previous $9.95 Billion 9.77%
% of portfolio
0.21%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $18.8 Million - $22.9 Million
-261,984 Reduced 0.21%
122,531,027 $8.98 Billion
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $251 Million - $284 Million
-3,422,449 Reduced 2.71%
122,793,011 $9.95 Billion
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $1.57 Million - $1.72 Million
21,281 Added 0.02%
126,215,460 $9.46 Billion
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $27.5 Million - $31.4 Million
-362,347 Reduced 0.29%
126,194,179 $9.73 Billion
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $387 Million - $441 Million
-5,003,724 Reduced 3.8%
126,556,526 $10.5 Billion
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $193 Million - $277 Million
3,099,517 Added 2.41%
131,560,250 $11.3 Billion
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $90.7 Million - $104 Million
1,523,122 Added 1.2%
128,460,733 $7.92 Billion
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $302 Million - $340 Million
5,228,246 Added 4.3%
126,937,611 $7.85 Billion
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $159 Million - $199 Million
2,748,159 Added 2.31%
121,709,365 $7.24 Billion
Q4 2021

Feb 10, 2022

SELL
$64.88 - $73.64 $131 Million - $149 Million
-2,021,143 Reduced 1.67%
118,961,206 $8.64 Billion
Q3 2021

Nov 09, 2021

SELL
$67.69 - $73.03 $191 Million - $206 Million
-2,822,189 Reduced 2.28%
120,982,349 $8.45 Billion
Q2 2021

Aug 11, 2021

BUY
$63.47 - $69.35 $7.86 Billion - $8.59 Billion
123,804,538 New
123,804,538 $8.53 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $80.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.